Boston Therapeutics, Inc.
BTHE · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,474,289 | -$3,579 | -$14,030 | -$356 |
| Dep. & Amort. | $42 | $17 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $84 | $0 | $0 | $0 |
| Change in WC | -$833 | $1,109 | $5,582 | -$356 |
| Other Non-Cash | $2,470,756 | $1,311 | $8,268 | $576 |
| Operating Cash Flow | -$4,240 | -$1,142 | -$180 | -$136 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$318 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $63 | $32 | $0 | $0 |
| Investing Cash Flow | -$255 | $32 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $23 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,860 | $5,016 | $220 | $25 |
| Financing Cash Flow | $6,860 | $5,016 | $220 | $25 |
| Forex Effect | -$3,941 | $8 | $0 | $0 |
| Net Chg. in Cash | -$1,576 | $3,913 | $40 | -$111 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,960 | $47 | $7 | $118 |
| End Cash | $2,384 | $3,960 | $47 | $7 |
| Free Cash Flow | -$4,558 | -$1,142 | -$180 | -$136 |